Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathyKobra Haghighi, Fotis Kolokathis, Anthony O Gramolini, et al.European Journal of Heart Failure|July 17, 2015
Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractilityWen-Feng Cai, Guan-Sheng Liu, Chi Keung Lam, et al.Journal of Molecular and Cellular Cardiology|November 25, 2017
HAX-1 regulates SERCA2a oxidation and degradationPhilip A Bidwell, Guan-Sheng Liu, Narayani Nagarajan, et al.Autophagy|November 22, 2017
Regulation of BECN1-mediated autophagy by HSPB6: Insights from a human HSPB6S10F mutantGuan-Sheng Liu, Hongyan Zhu, Wen-Feng Cai, et al.The Journal of Clinical Investigation|March 18, 2003
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophyQiujing Song, Albrecht G Schmidt, Harvey S Hahn, et al.Circulation Research|April 16, 2011
Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cyclingJiang Qian, Elizabeth Vafiadaki, Stela M Florea, et al.The Journal of Clinical Investigation|March 18, 2003
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and humanKobra Haghighi, Fotis Kolokathis, Luke Pater, et al.Journal of Molecular and Cellular Cardiology|October 13, 2015
Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmiasKobra Haghighi, Tracy J Pritchard, Guan-Sheng Liu, et al.Journal of the American Heart Association|October 16, 2013
Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding proteinVivek P Singh, Jack Rubinstein, Demetrios A Arvanitis, et al.Nature Medicine|October 21, 2025
Cardiotropic AAV gene therapy for heart failure: a phase 1 trialTimothy D Henry, Eugene S Chung, Monica Alvisi, et al.Pageof 4